Relapsed/refractory ALK+ anaplastic large cell lymphoma (ALCL), mantle cell lymphoma (MCL), and BCL6+ diffuse large B cell lymphoma (DLBCL) (NCT02572453). This evidence concerns the gene ALK and anaplastic large cell lymphoma.